Tag: cardiovascular protection
Finerenone Shows Cardiovascular Benefits in Non-Diabetic Chronic Kidney Disease Patients
Finerenone significantly reduces cardiovascular events by 14% in non-diabetic chronic kidney disease patients, according to landmark NEJM trial. The drug…
Submit Your Paper to GMJ
No APC until January 2027.